Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP400679.RAanC13s_V4JG1cKWZB1Uaj8-VP9a2DT-2zy6DN9VgxXU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP400679.RAanC13s_V4JG1cKWZB1Uaj8-VP9a2DT-2zy6DN9VgxXU130_assertion type Assertion NP400679.RAanC13s_V4JG1cKWZB1Uaj8-VP9a2DT-2zy6DN9VgxXU130_head.
- NP400679.RAanC13s_V4JG1cKWZB1Uaj8-VP9a2DT-2zy6DN9VgxXU130_assertion description "[First, they illustrate the necessity of clinically approved assays to identify FGFR1 gene amplification, which occur in approximately 5% of breast tumors and have been linked to antiestrogen resistance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP400679.RAanC13s_V4JG1cKWZB1Uaj8-VP9a2DT-2zy6DN9VgxXU130_provenance.
- NP400679.RAanC13s_V4JG1cKWZB1Uaj8-VP9a2DT-2zy6DN9VgxXU130_assertion evidence source_evidence_literature NP400679.RAanC13s_V4JG1cKWZB1Uaj8-VP9a2DT-2zy6DN9VgxXU130_provenance.
- NP400679.RAanC13s_V4JG1cKWZB1Uaj8-VP9a2DT-2zy6DN9VgxXU130_assertion SIO_000772 22879364 NP400679.RAanC13s_V4JG1cKWZB1Uaj8-VP9a2DT-2zy6DN9VgxXU130_provenance.
- NP400679.RAanC13s_V4JG1cKWZB1Uaj8-VP9a2DT-2zy6DN9VgxXU130_assertion wasDerivedFrom befree-20150227 NP400679.RAanC13s_V4JG1cKWZB1Uaj8-VP9a2DT-2zy6DN9VgxXU130_provenance.
- NP400679.RAanC13s_V4JG1cKWZB1Uaj8-VP9a2DT-2zy6DN9VgxXU130_assertion wasGeneratedBy ECO_0000203 NP400679.RAanC13s_V4JG1cKWZB1Uaj8-VP9a2DT-2zy6DN9VgxXU130_provenance.